{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:24:23Z","timestamp":1787689463142,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-02950-4","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:59:04Z","timestamp":1787644744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparable treatment response rates with benzathine penicillin and doxycycline in early syphilis: evidence from a large German cohort"],"prefix":"10.1007","author":[{"given":"Michael","family":"Sabranski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Knud","family":"Schewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Buhk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"1","key":"2950_CR1","doi-asserted-by":"publisher","first-page":"11386","DOI":"10.1038\/s41598-023-38294-4","volume":"13","author":"T Chen","year":"2023","unstructured":"Chen T, Wan B, Wang M, Lin S, Wu Y, Huang J. Evaluating the global, regional, and national impact of syphilis: results from the global burden of disease study 2019. Sci Rep. 2023;13(1):11386. https:\/\/doi.org\/10.1038\/s41598-023-38294-4.","journal-title":"Sci Rep"},{"issue":"1","key":"2950_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s40471-018-0138-z","volume":"5","author":"N Kojima","year":"2018","unstructured":"Kojima N, Klausner JD. An Update on the Global Epidemiology of Syphilis. Curr Epidemiol Rep. 2018;5(1):24\u201338. https:\/\/doi.org\/10.1007\/s40471-018-0138-z.","journal-title":"Curr Epidemiol Rep"},{"issue":"8","key":"2950_CR3","doi-asserted-by":"publisher","first-page":"e1110","DOI":"10.1016\/S2214-109X(21)00221-7","volume":"9","author":"M Tsuboi","year":"2021","unstructured":"Tsuboi M, Evans J, Davies EP, Rowley J, Korenromp EL, Clayton T, et al. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20. Lancet Glob Health. 2021;9(8):e1110\u20138. https:\/\/doi.org\/10.1016\/S2214-109X(21)00221-7.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"2950_CR4","doi-asserted-by":"publisher","first-page":"e1649","DOI":"10.1016\/S2214-109X(21)00449-6","volume":"9","author":"RM Chico","year":"2021","unstructured":"Chico RM, Tsuboi M, Evans J, Davies EP, Rowley J, Korenromp EL, et al. Estimating burden of syphilis among men who have sex with men - authors\u2019 reply. Lancet Glob Health. 2021;9(12):e1649. https:\/\/doi.org\/10.1016\/S2214-109X(21)00449-6.","journal-title":"Lancet Glob Health"},{"key":"2950_CR5","doi-asserted-by":"publisher","unstructured":"Jansen K, Bremer V. Syphilis in Deutschland in den Jahren 2020\u20132022 - Neuer H\u00f6chststand von Infektionen nach R\u00fcckgang w\u00e4hrend der COVID-19-Pandemie. Epid Bull. 2024. https:\/\/doi.org\/10.25646\/13461.3.","DOI":"10.25646\/13461.3"},{"issue":"11","key":"2950_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00105-020-04672-6","volume":"71","author":"H Sch\u00f6fer","year":"2020","unstructured":"Sch\u00f6fer H, Enders M, Esser S, Feiterna-Sperling C, Hagedorn H, Magistro G, et al. Diagnosis and treatment of syphilis: update of the S2k guidelines 2020 of the German STI Society (DSTIG) in cooperation with the following specialist societies: DAIG, dagn\u00e4, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI. RKI Hautarzt. 2020;71(11):969\u201399. https:\/\/doi.org\/10.1007\/s00105-020-04672-6.","journal-title":"RKI Hautarzt"},{"issue":"9","key":"2950_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMoa2401802","volume":"393","author":"EW Hook","year":"2025","unstructured":"Hook 3rd EW, Dionne JA, Workowski K, McNeil CJ, Taylor SN, Batteiger TA, et al. One dose versus three doses of benzathine penicillin G in early syphilis. N Engl J Med. 2025;393(9):869\u201378. https:\/\/doi.org\/10.1056\/NEJMoa2401802.","journal-title":"N Engl J Med"},{"issue":"10","key":"2950_CR8","doi-asserted-by":"publisher","first-page":"e109813","DOI":"10.1371\/journal.pone.0109813","volume":"9","author":"JC Tsai","year":"2014","unstructured":"Tsai JC, Lin YH, Lu PL, Shen NJ, Yang CJ, Lee NY, et al. Comparison of serological response to doxycycline versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients: a multi-center observational study. PLoS ONE. 2014;9(10):e109813. https:\/\/doi.org\/10.1371\/journal.pone.0109813.","journal-title":"PLoS ONE"},{"issue":"3","key":"2950_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/hiv.12985","volume":"22","author":"G Paul","year":"2021","unstructured":"Paul G, Wesselmann J, Adzic D, Malin JJ, Suarez I, Priesner V, et al. Predictors of serofast state after treatment for early syphilis in HIV-infected patients. HIV Med. 2021;22(3):165\u201371. https:\/\/doi.org\/10.1111\/hiv.12985.","journal-title":"HIV Med"},{"issue":"5","key":"2950_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.clindermatol.2010.03.012","volume":"28","author":"D Farhi","year":"2010","unstructured":"Farhi D, Dupin N. Management of syphilis in the HIV-infected patient: facts and controversies. Clin Dermatol. 2010;28(5):539\u201345. https:\/\/doi.org\/10.1016\/j.clindermatol.2010.03.012.","journal-title":"Clin Dermatol"},{"issue":"Suppl 1","key":"2950_CR11","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1093\/cid\/ciaa306","volume":"71","author":"S Tuddenham","year":"2020","unstructured":"Tuddenham S, Katz SS, Ghanem KG. Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests. Clin Infect Dis. 2020;71(Suppl 1):S21\u201342. https:\/\/doi.org\/10.1093\/cid\/ciaa306.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2950_CR12","doi-asserted-by":"publisher","first-page":"e0010021","DOI":"10.1128\/JCM.00100-21","volume":"59","author":"F Satyaputra","year":"2021","unstructured":"Satyaputra F, Hendry S, Braddick M, Sivabalan P, Norton R. The laboratory diagnosis of syphilis. J Clin Microbiol. 2021;59(10):e0010021. https:\/\/doi.org\/10.1128\/JCM.00100-21.","journal-title":"J Clin Microbiol"},{"issue":"18","key":"2950_CR13","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1001\/jama.2014.2087","volume":"312","author":"ME Clement","year":"2014","unstructured":"Clement ME, Hicks CB. RPR and the serological diagnosis of syphilis. JAMA. 2014;312(18):1922\u20133. https:\/\/doi.org\/10.1001\/jama.2014.2087.","journal-title":"JAMA"},{"issue":"Suppl2","key":"2950_CR14","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1093\/cid\/ciac060","volume":"74","author":"S Tuddenham","year":"2022","unstructured":"Tuddenham S, Ghanem KG. Management of adult syphilis: key questions to inform the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74(Suppl2):S127\u201333. https:\/\/doi.org\/10.1093\/cid\/ciac060.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2950_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/OLQ.0000000000001387","volume":"48","author":"K Ghanem","year":"2021","unstructured":"Ghanem K, Hook E. The terms serofast and serological nonresponse in the modern syphilis era. Sex Transm Dis. 2021;48(6):451\u20132. https:\/\/doi.org\/10.1097\/OLQ.0000000000001387.","journal-title":"Sex Transm Dis"},{"issue":"12","key":"2950_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-114-12-1005","volume":"114","author":"B Romanowski","year":"1991","unstructured":"Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serological response to treatment of infectious syphilis. Ann Intern Med. 1991;114(12):1005\u20139. https:\/\/doi.org\/10.7326\/0003-4819-114-12-1005.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2950_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1\u2013187. https:\/\/doi.org\/10.15585\/mmwr.rr7004a1.","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2950_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12879-017-2715-z","volume":"17","author":"Z Luo","year":"2017","unstructured":"Luo Z, Zhu L, Ding Y, Yuan J, Li W, Wu Q, et al. Factors associated with syphilis treatment failure and reinfection: a longitudinal cohort study in Shenzhen, China. BMC Infect Dis. 2017;17(1):620. https:\/\/doi.org\/10.1186\/s12879-017-2715-z.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"2950_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1610-0387.2006.06072.x","volume":"4","author":"S Lautenschlager","year":"2006","unstructured":"Lautenschlager S. Diagnosis of syphilis: clinical and laboratory problems. J Dtsch Dermatol Ges. 2006;4(12):1058\u201375. https:\/\/doi.org\/10.1111\/j.1610-0387.2006.06072.x.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2950_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12879-015-1209-0","volume":"15","author":"AC Sena","year":"2015","unstructured":"Sena AC, Zhang XH, Li T, Zheng HP, Yang B, Yang LG, et al. A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy. BMC Infect Dis. 2015;15:479. https:\/\/doi.org\/10.1186\/s12879-015-1209-0.","journal-title":"BMC Infect Dis"},{"key":"2950_CR21","doi-asserted-by":"publisher","first-page":"119754","DOI":"10.1016\/j.cca.2024.119754","volume":"560","author":"Q Cao","year":"2024","unstructured":"Cao Q, Li Y, Hu Y, He B, Tang Y, Cao T, et al. Serofast status in syphilis: pathogenesis to therapeutics. Clin Chim Acta. 2024;560:119754. https:\/\/doi.org\/10.1016\/j.cca.2024.119754.","journal-title":"Clin Chim Acta"},{"key":"2950_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciag099","author":"RA Pugsley","year":"2026","unstructured":"Pugsley RA, Davis NL, Cope AB, Diesel JC, Matthias J, Danforth B, et al. Is three really what we need? Relative effectiveness of benzathine penicillin G and doxycycline treatment regimens for late or unknown duration syphilis in 6 United States jurisdictions, 2016\u20132021. Clin Infect Dis. 2026. https:\/\/doi.org\/10.1093\/cid\/ciag099.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2950_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/cid\/cit146","volume":"56","author":"J Dionne-Odom","year":"2013","unstructured":"Dionne-Odom J, Karita E, Kilembe W, Henderson F, Vwalika B, Bayingana R, et al. Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis. 2013;56(12):1829\u201337. https:\/\/doi.org\/10.1093\/cid\/cit146.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2950_CR24","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis757","volume":"55","author":"DF Knaute","year":"2012","unstructured":"Knaute DF, Graf N, Lautenschlager S, Weber R, Bosshard PP. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis. 2012;55(12):1615\u201322. https:\/\/doi.org\/10.1093\/cid\/cis757.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2950_CR25","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1258\/095646207782717018","volume":"18","author":"K Manavi","year":"2007","unstructured":"Manavi K, McMillan A. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS. 2007;18(12):814\u20138. https:\/\/doi.org\/10.1258\/095646207782717018.","journal-title":"Int J STD AIDS"},{"issue":"12","key":"2950_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJMoa044284","volume":"353","author":"G Riedner","year":"2005","unstructured":"Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005;353(12):1236\u201344. https:\/\/doi.org\/10.1056\/NEJMoa044284.","journal-title":"N Engl J Med"},{"issue":"24","key":"2950_CR27","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/jcm11247499","volume":"11","author":"V Marchese","year":"2022","unstructured":"Marchese V, Tiecco G, Storti S, Degli Antoni M, Calza S, Gulletta M, et al. Syphilis infections, reinfections and serological response in a large Italian sexually transmitted disease centre: a monocentric retrospective study. J Clin Med. 2022;11(24):7499. https:\/\/doi.org\/10.3390\/jcm11247499.","journal-title":"J Clin Med"},{"issue":"2","key":"2950_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1086\/589295","volume":"47","author":"KG Ghanem","year":"2008","unstructured":"Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serological failure rates for syphilis among HIV-infected patients. Clin Infect Dis. 2008;47(2):258\u201365. https:\/\/doi.org\/10.1086\/589295.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2950_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/09564624221086471","volume":"33","author":"HZ Gong","year":"2022","unstructured":"Gong HZ, Li J, Zheng HY. The treatment outcome and predictors of serological response in syphilis in a sexually transmitted infections center, China. Int J STD AIDS. 2022;33(6):575\u201383. https:\/\/doi.org\/10.1177\/09564624221086471.","journal-title":"Int J STD AIDS"},{"key":"2950_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/1471-2334-13-605","volume":"13","author":"S Jinno","year":"2013","unstructured":"Jinno S, Anker B, Kaur P, Bristow CC, Klausner JD. Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect Dis. 2013;13:605. https:\/\/doi.org\/10.1186\/1471-2334-13-605.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2950_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/OLQ.0000000000000541","volume":"44","author":"AC Sena","year":"2017","unstructured":"Sena AC, Wolff M, Behets F, Martin DH, Leone P, Langley C, et al. Rate of decline in nontreponemal antibody titers and seroreversion after treatment of early syphilis. Sex Transm Dis. 2017;44(1):6\u201310. https:\/\/doi.org\/10.1097\/OLQ.0000000000000541.","journal-title":"Sex Transm Dis"},{"issue":"7","key":"2950_CR32","doi-asserted-by":"publisher","first-page":"e70102","DOI":"10.1371\/journal.pone.0070102","volume":"8","author":"ML Tong","year":"2013","unstructured":"Tong ML, Lin LR, Liu GL, Zhang HL, Zeng YL, Zheng WH, et al. Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS ONE. 2013;8(7):e70102. https:\/\/doi.org\/10.1371\/journal.pone.0070102.","journal-title":"PLoS ONE"},{"issue":"5","key":"2950_CR33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/infdis\/167.5.1100","volume":"167","author":"SA Baker-Zander","year":"1993","unstructured":"Baker-Zander SA, Shaffer JM, Lukehart SA. VDRL antibodies enhance phagocytosis of Treponema pallidum by macrophages. J Infect Dis. 1993;167(5):1100\u20135. https:\/\/doi.org\/10.1093\/infdis\/167.5.1100.","journal-title":"J Infect Dis"},{"issue":"11","key":"2950_CR34","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/cir671","volume":"53","author":"AC Sena","year":"2011","unstructured":"Sena AC, Wolff M, Martin DH, Behets F, Van Damme K, Leone P, et al. Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis. Clin Infect Dis. 2011;53(11):1092\u20139. https:\/\/doi.org\/10.1093\/cid\/cir671.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2950_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jama.2022.1246","volume":"327","author":"A Hazra","year":"2022","unstructured":"Hazra A, Collison MW, Davis AM. CDC sexually transmitted infections treatment guidelines, 2021. JAMA. 2022;327(9):870\u20131. https:\/\/doi.org\/10.1001\/jama.2022.1246.","journal-title":"JAMA"},{"issue":"1","key":"2950_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/0956462415573677","volume":"27","author":"RX Ren","year":"2016","unstructured":"Ren RX, Wang LN, Zheng HY, Li J. No improvement in serological response among serofast latent patients retreated with benzathine penicillin. Int J STD AIDS. 2016;27(1):58\u201362. https:\/\/doi.org\/10.1177\/0956462415573677.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"2950_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/cid\/cis918","volume":"56","author":"AC Sena","year":"2013","unstructured":"Sena AC, Wolff M, Behets F, Van Damme K, Martin DH, Leone P, et al. Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin. Clin Infect Dis. 2013;56(3):420\u20132. https:\/\/doi.org\/10.1093\/cid\/cis918.","journal-title":"Clin Infect Dis"},{"key":"2950_CR38","doi-asserted-by":"publisher","first-page":"1758075","DOI":"10.3389\/fimmu.2026.1758075","volume":"17","author":"YX Zeng","year":"2026","unstructured":"Zeng YX, Yang L, He YY, Deng ZL, Ke WJ, Wang HY. An integrated immunopathological model of syphilis serofast: a systematic review and meta-analysis. Front Immunol. 2026;17:1758075. https:\/\/doi.org\/10.3389\/fimmu.2026.1758075.","journal-title":"Front Immunol"},{"issue":"2","key":"2950_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/sti.2006.021402","volume":"83","author":"KG Ghanem","year":"2007","unstructured":"Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect. 2007;83(2):97\u2013101. https:\/\/doi.org\/10.1136\/sti.2006.021402.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"2950_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12879-018-3399-8","volume":"18","author":"C Kenyon","year":"2018","unstructured":"Kenyon C, Osbak KK, Crucitti T, Kestens L. Syphilis reinfection is associated with an attenuated immune profile in the same individual: a prospective observational cohort study. BMC Infect Dis. 2018;18(1):479. https:\/\/doi.org\/10.1186\/s12879-018-3399-8.","journal-title":"BMC Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02950-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:02:27Z","timestamp":1787688147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02950-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":40,"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02950-4","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Hamburg Medical Association issued a determination of non-jurisdiction (reference 2025-300-657-WF) because the study used fully anonymized data and did not constitute research requiring ethics committee consultation.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}